Quality of life for hepatitis C patients with a formulation...

Details Quality of life for hepatitis C patients with a formulation... Quality of life for hepatitis C patients with a formulation...

2011-08-30

2011-08-30

Davis, Ruth (Department: 1651)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C424S400000, C435S242000, C435S252900

Reexamination Certificate

active

08007783

ABSTRACT:
Disclosed are quick dissolve tablets, each includingLactobacillus delbrueckiisubspbulgaricus(LBD) and N-acetyl-glucosamine (NAG), as well as excipients, for oral mucosal administration, for improving the quality of life of Hepatitis C patients. Any formulation suitable for oral mucosal administration can be employed for administering the active ingredients in a sufficient dosage for therapeutic effect, one such formulation being: 50 mg ofLactobacillus delbrueckiisubspbulgaricuslysate strain YB-I 10 mg of N-acetyl D-glucosamine. Excipients can include one or more of, maltodextrin; xanthan gum; acesulfam K; lemon powder and a flavoring, e.g., juice; Mannitol TL-32-04, Microcrystalline Cellulose and Carrageenan, Fructose, PVP-XL TL-11-04, Gellan Gum, Citrus TL 1-04, Orange TL 19-04, Sucrolose TL-13-04, and Mg ST TL-13-04.

REFERENCES:
patent: 5716615 (1998-02-01), Cavaliere Vesely et al.
patent: 6281191 (2001-08-01), Slesarev et al.

Affiliated with

Also associated with

Rating

Quality of life for hepatitis C patients with a formulation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quality of life for hepatitis C patients with a formulation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quality of life for hepatitis C patients with a formulation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2718927